NAVIGATOR: Tezepelumab Could Transform Severe Uncontrolled Asthma Care

AstraZeneca/Amgen's Positive Top-Line Phase III Results

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.